Annotation Detail for SEMA5A
Basic Information
TopGene Symbol: | SEMA5A ( FLJ12815,SEMAF,semF ) |
---|
Gene Full Name: | sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A |
---|
Band: | 5p15.31 |
---|
Quick Links | Entrez ID:9037; OMIM: 609297; Uniprot ID:SEM5A_HUMAN; ENSEMBL ID: ENSG00000112902; HGNC ID: 10736 |
---|
Relate to Another Database: |
SFARIGene;
denovo-db |
Pathway ID | Pathway Name |
---|
hsa04360 | Axon guidance |
Pathway ID | Pathway Name |
---|
| Axon guidance |
Pathway ID | Pathway Name |
---|
500078 | Other semaphorin interactions |
Desease ID | Desease Name |
---|
2124 | Autistic disorder |
Desease Name |
---|
Parkinson's disease |
PSYCH |
NEUROLOGICAL |
Autism |
Desease Name |
---|
Parkinson's disease |
Autism |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C010914 |
2,4-diaminotoluene |
2,4-diaminotoluene results in increased expression of SEMA5A mRNA | increases expression | 20713471
|
C014949 |
acetylhydrazine |
acetylhydrazine results in decreased expression of SEMA5A mRNA | decreases expression | 15282401
|
D001149 |
Arsenates |
[Atrazine co-treated with Arsenates] results in increased expression of SEMA5A mRNA | affects cotreatment|increases expression | 18585445
|
C015001 |
arsenite |
[arsenite co-treated with Benzo(a)pyrene] results in decreased expression of SEMA5A mRNA | affects cotreatment|decreases expression | 15894712
|
C015001 |
arsenite |
arsenite results in decreased expression of SEMA5A mRNA | decreases expression | 15894712
|
D001280 |
Atrazine |
[Atrazine co-treated with Arsenates] results in increased expression of SEMA5A mRNA | affects cotreatment|increases expression | 18585445
|
D001564 |
Benzo(a)pyrene |
[arsenite co-treated with Benzo(a)pyrene] results in decreased expression of SEMA5A mRNA | affects cotreatment|decreases expression | 15894712
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of SEMA5A mRNA | decreases expression | 15894712 20713471
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in increased expression of SEMA5A mRNA | increases expression | 12057914
|
D008748 |
Methylcholanthrene |
Methylcholanthrene results in increased expression of SEMA5A mRNA | increases expression | 20713471
|
C008493 |
methylselenic acid |
methylselenic acid results in increased expression of SEMA5A mRNA | increases expression | 18548127
|
C029938 |
nickel sulfate |
nickel sulfate results in increased expression of SEMA5A mRNA | increases expression | 16780908
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of SEMA5A mRNA | affects binding|increases activity|increases expression | 19710929
|
D012645 |
Selenomethionine |
Selenomethionine affects the expression of SEMA5A mRNA | affects expression | 17222674
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
16.03 | 18653653 11850527 |
MESH:D055371 |
Acute Lung Injury |
|
nickel sulfate |
16.03 | 11954676 16100012 19131640 12718980 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
16.03 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
2.01 | 20127859 20464547 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
7.07 | 6695378 |
MESH:D000236 |
Adenoma |
|
Methylcholanthrene |
7.07 | 6695378 10545420 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
3.63 | 16434500 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Atrazine |
4.38 | 11874814 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.21 | 19183758 |
MESH:D050197 |
Atherosclerosis |
|
Methylcholanthrene |
3.51 | 11922910 |
MESH:D001321 |
Autistic Disorder |
marker/mechanism |
|
| 17028446 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.26 | 19483382 |
MESH:D001943 |
Breast Neoplasms |
|
2,4-diaminotoluene |
2.08 | 11921183 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.08 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Methylcholanthrene |
2.08 | 17474063 |
MESH:D002277 |
Carcinoma |
|
Methylcholanthrene |
4.05 | 10545420 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
2.08 | 20419170 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylcholanthrene |
3.57 | 16192471 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
2.91 | 19176532 |
MESH:D003110 |
Colonic Neoplasms |
|
arsenite |
2.60 | 15037631 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
nickel sulfate |
3.81 | 16823706 11298694 16780908 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.47 | 18249437 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.59 | 12083418 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
4.55 | 17637181 15821434 15328337 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
2.03 | 16530937 |
MESH:D005234 |
Fatty Liver |
|
arsenite |
8.27 | 18296743 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
8.27 | 19236843 20131406 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
4.12 | 11852909 9205823 |
MESH:D005354 |
Fibrosarcoma |
|
Methylcholanthrene |
5.09 | 14633661 10962813 |
MESH:D005355 |
Fibrosis |
|
arsenite |
4.20 | 18296743 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
2.71 | 20471113 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.60 | 20558911 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
4.49 | 16366002 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.13 | 18467677 19772884 16221962 19176532 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.29 | 20558911 |
MESH:D007248 |
Infertility, Male |
|
Atrazine |
3.78 | 12948887 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
2.92 | 9205823 17237260 12878042 17255318 17963957 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.70 | 16306350 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
4.75 | 17255318 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
4.85 | 15821434 |
MESH:D008103 |
Liver Cirrhosis |
|
arsenite |
3.47 | 18296743 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
2.54 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.54 | 15474484 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
4.49 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
4.49 | 20007298 15890375 16377806 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Methylcholanthrene |
3.34 | 1399818 598648 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
4.15 | 21114838 |
MESH:D008175 |
Lung Neoplasms |
|
arsenite |
3.64 | 16809336 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
3.64 | 18569708 6695378 18520028 20135361 20464547 18816296 17053015 20064080 20869020 |
MESH:D008175 |
Lung Neoplasms |
|
Methylcholanthrene |
3.64 | 20970405 6695378 15390079 21163286 7750092 20512841 9230183 10545420 16337739 11893704 16271038 1399818 17909032 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
2,4-diaminotoluene |
3.64 | 11921183 |
MESH:D008654 |
Mesothelioma |
|
Atrazine |
3.56 | 1916698 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.27 | 16381670 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.64 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.18 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.03 | 16411023 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
4.99 | 11141357 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
4.99 | 17405874 |
MESH:D009389 |
Neovascularization, Pathologic |
|
arsenite |
4.57 | 15738583 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.84 | 20558911 |
MESH:D010300 |
Parkinson Disease |
|
Atrazine |
3.31 | 17218051 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
4.71 | 12224865 11605937 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
3.38 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
methylselenic acid |
3.38 | 16205645 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.43 | 19058328 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.80 | 10835634 |
MESH:D012135 |
Respiratory Sounds |
|
Atrazine |
4.65 | 11874814 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
2.41 | 10029692 19755658 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
1.56 | 2093021 20155912 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
4.27 | 15821434 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
2.21 | 17053015 |
PharmGKB Accession:PA35658
Releated disease ID |
Related disease Name |
PA445254 | Parkinson Disease |